Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

189 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impaired myocardial perfusion is a major explanation of the poor outcome observed in patients undergoing primary angioplasty for ST-segment-elevation myocardial infarction and signs of heart failure.
De Luca G, van 't Hof AW, de Boer MJ, Hoorntje JC, Gosselink AT, Dambrink JH, Ottervanger JP, Zijlstra F, Suryapranata H. De Luca G, et al. Among authors: dambrink jh. Circulation. 2004 Mar 2;109(8):958-61. doi: 10.1161/01.CIR.0000120504.31457.28. Epub 2004 Feb 23. Circulation. 2004. PMID: 14981008
Routine upstream versus selective down stream use of tirofiban in non-ST elevation myocardial infarction patients scheduled for early invasive therapy; a randomized comparison.
Rasoul S, Ottervanger JP, de Boer MJ, Dambrink JH, Suryapranata H, Hoorntje JC, Gosselink AT, van 't Hof AW; ELISA study group. Rasoul S, et al. Among authors: dambrink jh. J Thromb Thrombolysis. 2007 Dec;24(3):241-6. doi: 10.1007/s11239-007-0015-y. Epub 2007 Mar 2. J Thromb Thrombolysis. 2007. PMID: 17334935 Clinical Trial.
Pre-hospital administration of tirofiban in diabetic patients with ST-elevation myocardial infarction undergoing primary angioplasty: a sub-analysis of the On-Time 2 trial.
Timmer JR, ten Berg J, Heestermans AA, Dill T, van Werkum JW, Dambrink JH, Suryapranata H, Ottervanger JP, Hamm C, van 't Hof AW; Ongoing Tirofiban In Myocardial Infarction Evaluation (On - Time) 2 study group. Timmer JR, et al. Among authors: dambrink jh. EuroIntervention. 2010 Aug;6(3):336-42. doi: 10.4244/EIJV6I3A56. EuroIntervention. 2010. PMID: 20884411 Clinical Trial.
Is the difference in outcome between men and women treated by primary percutaneous coronary intervention age dependent? Gender difference in STEMI stratified on age.
Otten AM, Maas AH, Ottervanger JP, Kloosterman A, van 't Hof AW, Dambrink JH, Gosselink AT, Hoorntje JC, Suryapranata H, de Boer MJ; Zwolle Myocardial Infarction study Group. Otten AM, et al. Among authors: dambrink jh. Eur Heart J Acute Cardiovasc Care. 2013 Dec;2(4):334-41. doi: 10.1177/2048872612475270. Epub 2013 Jan 31. Eur Heart J Acute Cardiovasc Care. 2013. PMID: 24338292 Free PMC article.
Influence of prehospital administration of aspirin and heparin on initial patency of the infarct-related artery in patients with acute ST elevation myocardial infarction.
Zijlstra F, Ernst N, de Boer MJ, Nibbering E, Suryapranata H, Hoorntje JC, Dambrink JH, van 't Hof AW, Verheugt FW. Zijlstra F, et al. Among authors: dambrink jh. J Am Coll Cardiol. 2002 Jun 5;39(11):1733-7. doi: 10.1016/s0735-1097(02)01856-9. J Am Coll Cardiol. 2002. PMID: 12039484 Free article.
A comparison of two invasive strategies in patients with non-ST elevation acute coronary syndromes: results of the Early or Late Intervention in unStable Angina (ELISA) pilot study. 2b/3a upstream therapy and acute coronary syndromes.
van 't Hof AW, de Vries ST, Dambrink JH, Miedema K, Suryapranata H, Hoorntje JC, Gosselink AT, Zijlstra F, de Boer MJ. van 't Hof AW, et al. Among authors: dambrink jh. Eur Heart J. 2003 Aug;24(15):1401-5. doi: 10.1016/s0195-668x(03)00259-8. Eur Heart J. 2003. PMID: 12909068 Clinical Trial.
189 results